Official US documents have disclosed that a popular anti-stroke medicine may have used fictitious data while concealing research on its fatal effects. In 2009, the acclaimed British medical journal, The Lancet, published a prime story on rivaroxaban, a blood thinner medicine, which showed that the treatment was safe and efficient. But recently, the same journal warned of defaults in the trial data and claimed to initiate an investigation over it.

Lancet opens probe into ‘unreliable’ anti-stroke medicine

Over 100 scientists have slammed Lancet Medical Journal over its study on using hydroxychloroquine (HCQ) to treat Covid-19. The authenticity of the study is under question. WION's Palki Sharma gets you a report.

Gravitas: Was Lancet study on Hydroxychloroquine fabricated?

scientists-have-slammed-lancet-medical-journal

Scientists Have Slammed Lancet Medical Journal, News on Scientists Have Slammed Lancet Medical Journal, stories on Scientists Have Slammed Lancet Medical Journal, articles on Scientists Have Slammed Lancet Medical Journal, Scientists Have Slammed Lancet Medical Journal stories at Wion, Scientists Have Slammed Lancet Medical Journal news, Scientists Have Slammed Lancet Medical Journal latest news

scientists have-slammed-lancet-medical-journal

Lancet opens probe into ‘unreliable’ anti-stroke medicine

Gravitas: Was Lancet study on Hydroxychloroquine fabricated?